Proceedings of the National Academy of Sciences,
Journal Year:
2024,
Volume and Issue:
121(19)
Published: April 30, 2024
Snakebite
envenoming
is
a
neglected
tropical
disease
that
causes
substantial
mortality
and
morbidity
globally.
The
venom
of
African
spitting
cobras
often
permanent
injury
via
tissue-destructive
dermonecrosis
at
the
bite
site,
which
ineffectively
treated
by
current
antivenoms.
To
address
this
therapeutic
gap,
we
identified
etiological
toxins
in
Naja
nigricollis
responsible
for
causing
local
dermonecrosis.
While
cytotoxic
three-finger
were
primarily
cobra
cytotoxicity
cultured
keratinocytes,
their
potentiation
phospholipases
A
2
was
essential
to
cause
vivo.
This
evidence
probable
toxin
synergism
suggests
single
toxin-family
inhibiting
drug
could
prevent
envenoming.
We
show
injection
with
repurposed
phospholipase
-inhibiting
varespladib
significantly
prevents
tissue
damage
caused
several
venoms
murine
models
Our
findings
therefore
provide
strategy
may
effectively
life-changing
snakebite
rural
Africa.
Briefings in Bioinformatics,
Journal Year:
2022,
Volume and Issue:
23(5)
Published: April 20, 2022
Proteins/peptides
have
shown
to
be
promising
therapeutic
agents
for
a
variety
of
diseases.
However,
toxicity
is
one
the
obstacles
in
protein/peptide-based
therapy.
The
current
study
describes
web-based
tool,
ToxinPred2,
developed
predicting
proteins.
This
an
update
ToxinPred
mainly
peptides
and
small
method
has
been
trained,
tested
evaluated
on
three
datasets
curated
from
recent
release
SwissProt.
To
provide
unbiased
evaluation,
we
performed
internal
validation
80%
data
external
remaining
20%
data.
We
implemented
following
techniques
protein
toxicity;
(i)
Basic
Local
Alignment
Search
Tool-based
similarity,
(ii)
Motif-EmeRging
with
Classes-Identification-based
motif
search
(iii)
Prediction
models.
Similarity
motif-based
achieved
high
probability
correct
prediction
poor
sensitivity/coverage,
whereas
models
based
machine-learning
balance
sensitivity
specificity
reasonably
accuracy.
Finally,
hybrid
that
combined
all
approaches
maximum
area
under
receiver
operating
characteristic
curve
around
0.99
Matthews
correlation
coefficient
0.91
dataset.
In
addition,
alternate
realistic
datasets.
best
machine
learning
web
server
named
'ToxinPred2',
which
available
at
https://webs.iiitd.edu.in/raghava/toxinpred2/
standalone
version
https://github.com/raghavagps/toxinpred2.
general
proteins
regardless
their
source
origin.
New England Journal of Medicine,
Journal Year:
2022,
Volume and Issue:
386(1), P. 68 - 78
Published: Jan. 5, 2022
Snake
envenomation
is
a
global
health
problem.
The
range
of
clinical
sequelae
includes
thromboses
and
neuromuscular
paralysis.
Antivenoms
made
in
horses
sheep
are
the
treatments
choice
but
require
accurate
identification
bite
source
can
cause
anaphylaxis
serum
sickness.
GigaScience,
Journal Year:
2022,
Volume and Issue:
11
Published: Jan. 1, 2022
Abstract
Venoms
have
evolved
>100
times
in
all
major
animal
groups,
and
their
components,
known
as
toxins,
been
fine-tuned
over
millions
of
years
into
highly
effective
biochemical
weapons.
There
are
many
outstanding
questions
on
the
evolution
toxin
arsenals,
such
how
venom
genes
originate,
contributes
to
fitness
venomous
species,
which
modifications
at
genomic,
transcriptomic,
protein
level
drive
evolution.
These
received
particularly
little
attention
outside
snakes,
cone
snails,
spiders,
scorpions.
Venom
compounds
further
become
a
source
inspiration
for
translational
research
using
diverse
bioactivities
various
applications.
We
highlight
here
recent
advances
new
strategies
modern
venomics
discuss
technological
innovations
multi-omic
methods
dramatically
improve
animals.
The
study
genomes
through
CRISPR
knockdown
technologies
will
increase
our
understanding
toxins
evolve
functions
they
different
ontogenetic
stages
during
development
Mass
spectrometry
imaging
combined
with
spatial
transcriptomics,
situ
hybridization
techniques,
computer
tomography
gives
us
insights
distribution
system
function
apparatus.
All
these
evolutionary
biological
contribute
more
efficiently
identify
compounds,
can
then
be
synthesized
or
produced
adapted
expression
systems
test
bioactivity.
Finally,
we
critically
agrochemical,
pharmaceutical,
therapeutic,
diagnostic
(so-called
translational)
aspects
venoms
from
humans
benefit.
Communications Biology,
Journal Year:
2024,
Volume and Issue:
7(1)
Published: March 22, 2024
Snakebite
envenoming
is
an
important
public
health
issue
responsible
for
mortality
and
severe
morbidity.
Where
mainly
caused
by
venom
toxins
that
induce
cardiovascular
disturbances,
neurotoxicity,
acute
kidney
injury,
morbidity
directly
or
indirectly
destroy
cells
degrade
the
extracellular
matrix.
These
are
referred
to
as
'tissue-damaging
toxins'
have
previously
been
classified
in
various
ways,
most
of
which
based
on
tissues
being
affected
(e.g.,
cardiotoxins,
myotoxins).
This
categorisation,
however,
primarily
phenomenological
not
mechanistic.
In
this
review,
we
propose
alternative
way
classifying
cytotoxins
their
mechanistic
effects
rather
than
using
a
description
organ-
tissue-based.
The
mechanisms
toxin-induced
tissue
damage
clinical
implications
discussed.
review
contributes
our
understanding
fundamental
biological
processes
associated
with
snakebite
envenoming,
may
pave
knowledge-based
search
novel
therapeutic
options.
Science Translational Medicine,
Journal Year:
2024,
Volume and Issue:
16(735)
Published: Feb. 21, 2024
Snakebite
envenoming
is
a
major
global
public
health
concern
for
which
improved
therapies
are
urgently
needed.
The
antigenic
diversity
present
in
snake
venom
toxins
from
various
species
presents
considerable
challenge
to
the
development
of
universal
antivenom.
Here,
we
used
synthetic
human
antibody
library
find
and
develop
an
that
neutralizes
long-chain
three-finger
α-neurotoxins
produced
by
numerous
medically
relevant
snakes.
Our
bound
diverse
toxin
variants
with
high
affinity,
blocked
binding
nicotinic
acetylcholine
receptor
vitro,
protected
mice
lethal
challenge.
Structural
analysis
antibody-toxin
complex
revealed
mode
mimics
receptor-toxin
interaction.
overall
workflow
presented
generalizable
antibodies
target
conserved
epitopes
among
antigenically
targets,
it
offers
promising
framework
creation
monoclonal
antibody–based
antivenom
treat
snakebite
envenoming.
Transactions of the Royal Society of Tropical Medicine and Hygiene,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 3, 2025
Abstract
Snake
venom,
a
complex
mixture
of
proteins,
has
attracted
human
attention
for
centuries
due
to
its
associated
mortality,
morbidity
and
other
therapeutic
properties.
In
sub-Saharan
Africa
(SSA),
where
snakebites
pose
significant
health
risk,
understanding
the
genetic
variability
snake
venoms
is
crucial
developing
effective
antivenoms.
The
wide
geographic
distribution
venomous
species
in
SSA
countries
demonstrates
need
develop
specific
broad
However,
development
antivenoms
been
hindered
by
different
factors,
such
as
antivenom
cross-reactivity
polygenic
paratopes.
While
have
numerous
across
region,
current
antivenoms,
SAIMR
polyvalent
Premium
Serums
&
Vaccines,
exhibit
varying
degrees
cross-reactivity.
Such
ability
cross-react
enables
target
multiple
components
from
species.
advent
biotechnological
innovations,
including
recombinant
antibodies,
small-molecule
drugs,
monoclonal
antibodies
synthetic
presents
options
eliminating
limitations
with
traditional
plasma-derived
challenges
still
persist,
especially
SSA,
addressing
variability,
evidenced
inadequate
testing
capacity
limited
genomic
research
facilities.
This
comprehensive
review
explores
emphasizing
venom
composition
various
their
interactions.
information
critical
strategies
during
development.
Finally,
it
offers
concerning
extensive
collaborative
engagements,
technological
advancements
evaluations
produce
targeted
PLoS neglected tropical diseases,
Journal Year:
2021,
Volume and Issue:
15(2), P. e0009150 - e0009150
Published: Feb. 18, 2021
Background
Snake
venom
composition
is
dictated
by
various
ecological
and
environmental
factors,
can
exhibit
dramatic
variation
across
geographically
disparate
populations
of
the
same
species.
This
molecular
diversity
undermine
efficacy
snakebite
treatments,
as
antivenoms
produced
against
from
one
population
may
fail
to
neutralise
others.
India
world’s
hotspot,
with
58,000
fatalities
140,000
morbidities
occurring
annually.
Spectacled
cobra
(
Naja
naja
)
Russell’s
viper
Daboia
russelii
are
known
cause
majority
these
envenomations,
in
part
due
their
near
country-wide
distributions.
However,
impact
differing
ecologies
environment
on
compositions
has
not
been
comprehensively
studied.
Methods
Here,
we
used
a
multi-disciplinary
approach
consisting
proteomics,
biochemical
pharmacological
analyses,
vivo
research
comparatively
analyse
N
.
venoms
broad
region
(>6000
km;
seven
populations)
covering
India’s
six
distinct
biogeographical
zones.
Findings
By
generating
most
comprehensive
pan-Indian
proteomic
toxicity
profiles
date,
unveil
considerable
differences
composition,
effects
potencies
geographically-distinct
this
species
and,
through
use
immunological
assays
preclinical
experiments,
demonstrate
alarming
repercussions
antivenom
therapy.
We
find
that
commercially-available
fails
effectively
envenomations
,
including
complete
lack
neutralisation
desert
population.
Conclusion
Our
findings
highlight
significant
influence
ecology
snake
potency,
stress
pressing
need
innovate
pan-India
effective
safeguard
lives,
limbs
livelihoods
country’s
200,000
annual
victims.
Toxins,
Journal Year:
2021,
Volume and Issue:
13(7), P. 451 - 451
Published: June 29, 2021
A
global
strategy,
under
the
coordination
of
World
Health
Organization,
is
being
unfolded
to
reduce
impact
snakebite
envenoming.
One
pillars
this
strategy
ensure
safe
and
effective
treatments.
The
mainstay
in
therapy
envenoming
administration
animal-derived
antivenoms.
In
addition,
new
therapeutic
options
are
explored,
including
recombinant
antibodies
natural
synthetic
toxin
inhibitors.
review,
snake
venom
toxins
classified
terms
their
abundance
toxicity,
priority
actions
proposed
search
for
metalloproteinase
(SVMP),
phospholipase
A2
(PLA2),
three-finger
(3FTx),
serine
proteinase
(SVSP)
Natural
inhibitors
include
compounds
isolated
from
plants,
animal
sera,
mast
cells,
whereas
comprise
a
wide
range
molecules
variable
chemical
nature.
Some
most
promising
inhibitors,
especially
SVMP
PLA2
have
been
developed
other
diseases
repurposed
drugs
aimed
at
controlling
endogenous
processes
generated
course
pursued.
present
review
summarizes
some
developments
field
discusses
issues
that
need
be
considered
translation
knowledge
improve
therapies
tackling